<qa>  What is the name of the PATIENTs that are ATEZOLIZUMABATEZOLIZUMAB, GEMCITABINE, OXALIPLATIN, AND RITUXIMAB IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY TRANSFORMED DIFFUSE LARGE B-CELL LYMPHOMA: 